19th July 2024, Colombo: Vision Care, Sri Lanka’s largest vision and eye wear solutions provider, recently celebrated the 14th anniversary of its Jaffna branch by organizing a highly successful free Eye & ENT camp at its premises. The event aimed to provide essential eye and ENT care to the community, promoting overall well-being and reaffirming the company’s dedication to enhancing the quality of life of the communities it serves.
Hundreds of patients visited the Eye & ENT camp throughout the day to have their eyes and hearing tested by the experienced healthcare professionals of Vision Care Jaffna branch. Based on the results, patients received personalized medical advice and recommendations for corrective measures, such as prescription glasses or contact lenses, and guidance on necessary follow-up treatments to ensure their vision & ENT health is maintained.
Vision Care’s Jaffna branch offers ample parking and a modern ambiance, featuring spacious interiors with a comprehensive range of products and services, including spectacles, sunglasses, contact lenses, and hearing aids. Equipped with cutting-edge eye care and hearing care equipment, the branch is staffed by highly trained professionals who deliver expert care. Customers can avail themselves of the latest eye care solutions and choose from an impressive selection of renowned global eyewear brands, such as Ray Ban, Boss, Vogue, Tommy Hilfiger, Carrera, Polo Ralph, Arnette and more. Additionally, the branch provides hearing care solutions from Oticon, a renowned manufacturer with over a century of experience in developing innovative hearing aids for both adults and children.
With over 30 years of service excellence, Vision Care is committed to providing high-quality eye and hearing care solutions to enhance the lives of its customers. The company has been at the forefront of the technological revolution in eye care in Sri Lanka by providing high-quality eye testing, spectacles, sunglasses, contact lenses, and hearing aids from world-renowned brands, along with ocular pharmaceuticals.